These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2783699

  • 1. A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders.
    Tamminen TT, Lehtinen VV.
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():51-6. PubMed ID: 2783699
    [No Abstract] [Full Text] [Related]

  • 2. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.
    Feighner JP, Cohn JB.
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):20-5. PubMed ID: 3882676
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P, Baker B, Irvine J, Dorian P, McKessok D, Mendlowitz S.
    Depress Anxiety; 1998 Mar; 7(2):69-72. PubMed ID: 9614594
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder.
    Feighner J, Hendrickson G, Miller L, Stern W.
    J Clin Psychopharmacol; 1986 Feb; 6(1):27-32. PubMed ID: 3081600
    [Abstract] [Full Text] [Related]

  • 6. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
    Feighner JP.
    J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.
    Titievsky J, Seco G, Barranco M, Kyle EM.
    J Clin Psychiatry; 1982 Nov; 43(11):454-6. PubMed ID: 7174622
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptiline.
    Altamura AC, Percudani M, Guercetti G, Invernizzi G.
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():103-6. PubMed ID: 2783697
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fluoxetine versus nomifensine in outpatients with neurotic or reactive depressive disorder.
    Taneri Z, Köhler R.
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():57-61. PubMed ID: 2783700
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
    Rickels K, Csanalosi I, Werblowsky J, Weise CC, Weinstock R, Brown AS, Winokur A, Von Poelnitz M.
    J Clin Psychiatry; 1982 Oct; 43(10):419-22. PubMed ID: 6749826
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low-dose fluoxetine therapy for depression.
    Wernicke JF, Dunlop SR, Dornseif BE, Bosomworth JC, Humbert M.
    Psychopharmacol Bull; 1988 Oct; 24(1):183-8. PubMed ID: 3290940
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL, Schatzberg AF, Rosenbaum A, Contreras SA, Samson JA, Dessain E, Sayler M.
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.